Business Review

POLYDOC PLC 25 August 1999 PolyDoc Plc SHAREHOLDER COMMUNICATION A business review of the first half of 1999 and the outlook for the remainder of the year from Barry Mence, Executive Chairman PolyDoc, a computer software company, which specialises in the development and provision of business solutions in the rapidly growing field of Knowledge Management announces its business highlights for the first half of 1999. Highlights: - Consistent levels of revenue from our long term contracts to install QualiFlow, our healthcare industry product, continue to form the foundation of our turnover. This revenue has been supplemented by both product and consultancy sales. Total turnover has shown a 14% increase compared to the same period in the previous year. With operating costs increasing in line with budget, pre-tax losses will be around £600,000 - Lessenger B.V., PolyDocs recently acquired supplier of document management software to the healthcare industry, brings additional revenue from both new and its existing 50 Dutch healthcare clients - StudyFlow pilot successfully evaluated by DERA, the Defence Evaluation and Research Agency related to the UK Ministry of Defence, resulting in additional development work being contracted - Knowledge Management Consultancy division launched and starting to contract first customers - PolyDoc and Hiscom announce agreement to collaborate on Medical Knowledge Management Systems to accelerate progress towards electronic patient dossiers for Dutch healthcare market - Letter of intent signed to acquire AppliedNet, a UK-based knowledge management software products, systems integration and consulting company. This would add a complementary product set, a solid blue-chip UK customer base, an additional existing revenue stream and more than 40 highly skilled UK staff. - First important business partnership agreements entered into in the UK and the USA - Senior software industry executive, Paul Heller, is appointed as Chief Technology Officer and a member of the management board of directors CHAIRMANS LETTER TO SHAREHOLDERS With the first half of 1999 now completed I would like to update you on PolyDocs progress during the past half year and to share with you our major objectives for the rest of the current year and beyond. Business review of the first half of 1999. Healthcare. Our first multimillion guilder contract involving three (from a total of eight) academic/teaching hospitals in the Netherlands is progressing well. Our QualiFlow software has continued to be delivered to the initial customers in the stages as planned enabling them to prepare for the important phase of content production. With further deliveries planned for October 1999 the environment has been created for all sizes of hospital to become customers of both QualiFlow software and content. We have had clear indications from the highest level at several hospitals, both academic and general, that they intend to contract for PolyDocs software to enable them to share the content with the first launching customers. We expect to sign further substantial business in this area during the current year, as we seek to establish our approach as a form of standard for the Dutch healthcare industry. As mentioned in a previous shareholder communication, a joint venture company called Pro-GRAM B.V. has been formed by the initial academic hospitals to market, together with PolyDoc, the QualiFlow software and the knowledge created using the software to a broad range of organisations in the Dutch healthcare industry. PolyDoc has accepted an invitation to become a shareholder in this company, which has at the start of this year commenced active marketing. Lessenger B.V., our recently acquired supplier of document management software to the healthcare industry, has been fully integrated into PolyDocs business. This has started to bring additional revenue from both new and its existing 50 Dutch healthcare clients. In addition to our commitment to the ongoing development, enhancement and support of these products, we will also ensure that our QualiFlow healthcare solution interfaces with the Lessenger family of products. This should put both PolyDoc and Pro-GRAM in a strong position to further accelerate our sales of QualiFlow in the substantial healthcare market. We have entered agreements with Hiscom in the Netherlands and Marlow in the U.K. which are more fully described under the Business Partnership section of this note. We are also in discussions in the U.K., U.S.A., Belgium and Germany with prospects and additional business partners that have shown serious interest in our Healthcare solution QualiFlow. Manufacturing and Defence. DSM, the multinational chemical manufacturer, went into full production early this year with the latest version (3.0) of NormFlow, our solution for the production and maintenance of standards for the manufacturing and process industries. We have extended the scope and use of the product at DSM resulting in additional revenue on top of the ongoing maintenance fees. We have contracted the services of two former senior executives of the Baan Company, Otto van der Tang and Henk Speksnijder to initiate the volume selling of this new enhanced NormFlow as well as the marketing of our ResearchFlow/StudyFlow solutions into this sector. This is presently underway, and we would expect to see the commercial results of this starting during the current year. The StudyFlow pilot we have been executing at DERA, the Defence Evaluation and Research Agency related to the UK Ministry of Defence, has been successfully evaluated resulting in further development work being contracted. Our plans for penetrating the Defence Industry have become closely linked to our Manufacturing strategy. This is because our early prospects apart from DERA are major defence industry manufacturers. One of these manufacturers is at the final stages of evaluating the implementation and benefits of PolyDocs solutions, and we would expect to see further work with that organisation and DERA in the second half of this year. Knowledge and Content Management Consultancy Services. Our new consultancy services group has now been established and is focussing on generating additional revenue as well as bringing potential software product customers and business partners into PolyDoc as paying services customers. Initial work of this nature has been contracted with DSM, Oci, DERA, IBM and KPMG in the first half of this year. Business Partnerships. Our strategy for expanding PolyDocs business into volume sales has always been to enter into business partnerships with mature organisations with strong customer bases, once we have established the early customers in our chosen focus industries. The initial target geographies remain the Benelux countries, the UK and the USA. In addition to the partnership covering the Benelux with the hospitals joint venture company, Pro-GRAM we have put two non- exclusive agreements in place with business partners in the United Kingdom and the United States. Marlow Consulting in United Kingdom specialises in management consultancy and systems integration, and they are focusing with PolyDocs products on a number of named accounts in the healthcare and pharmaceutical industries. TelTech, a recognised USA Knowledge Management specialist-consulting firm will be focussing on the manufacturing industry. All three partners have been working closely with PolyDoc staff on concrete business opportunities in the Netherlands, USA, UK and Germany. We are also in detailed discussions with a small number of software suppliers with substantial existing customer bases concerning the integration of parts of our software into theirs, which we believe could potentially form the start of a very lucrative revenue stream. Another important agreement we have entered into is with Hiscom in the Netherlands whereby we are to collaborate on medical knowledge systems to accelerate progress towards electronic patient dossiers for the Dutch healthcare market. Hiscom is the market leader in the medical IT market in the Netherlands, and is increasingly focusing on new Care information systems outside its local market, in particular in the United Kingdom, Germany and Scandinavia. We are currently discussing the potential for jointly pursuing commercial opportunities also in these geographies. Financial. Consistent levels of revenue from our long term contracts to install QualiFlow, our major healthcare industry product, continue to form the foundation of our turnover. This revenue has been supplemented by both Lessenger product and consultancy sales from our recently formed Consultancy group. Total turnover has shown a 14% increase compared to the same period in the previous year. With operating costs increasing in line with budget, pre-tax losses will be around £600,000. The convertible loan that was put in place last year was an interim term solution for our medium term capital requirements. These funds have been utilised to a point where as announced previously, we need to complete further more substantial fund raising in this current year. Initial indications from Institutions in the U.K. Financial Market have been positive as born out by the issuing of £500,000 of new ordinary shares to three new institutional investors earlier this year, at market price at the time (£1.47). The new funds to be raised will ensure we have the cash in place to meet our ongoing financial requirements, and to build upon our business successes in the Healthcare industry, by expanding into the UK and USA markets, replicating the successful formula we have developed in the Netherlands. Additionally, we will then be in a position to more fully exploit our potential in the lucrative Manufacturing and Defence industries, where we are currently working with our initial customers as mentioned earlier in this document. Further details of this fund raising will be announced during the coming months. Outlook for the second half of 1999 and beyond Following the successful integration of our first acquisition and in line with our acquisition strategy, we are actively working with a number of European companies to evaluate the benefits of them becoming part of PolyDoc. The most important development in this area is the signing of a letter of intent to purchase AppliedNet, a UK-based software products, systems integration and consulting company. Upon completion this will be a significant step forward and a major milestone in our business development, with the acquisition providing the necessary critical mass and additional resources to broaden and accelerate sales in the European marketplace, and to expand faster into the United States. Additionally, AppliedNets impressive UK client portfolio, comprising blue- chip multinationals, defence and publishing organisations, would significantly enhance our overall customer base and brings an important further revenue stream. We firmly believe that the combination of AppliedNets knowledge harvesting software and web publishing solutions together with PolyDocs knowledge capture and content management software would create a very competitive and highly commercial range of solutions in the fast emerging knowledge management and e-business marketplaces. With our push into the United States starting to take shape via our business partnership agreements and our small team of senior executives led by Paul Heller, we are then targeting the year 2000 for an acquisition in that territory. Recent months have seen several important announcements in the Knowledge Management arena from market leader software companies like Microsoft. Not only is this starting to increase potential customers focus on purchasing Knowledge Management software, it is adding substantial credibility to PolyDocs software solutions. In particular, this is because our software is complementary to that being brought to market by the likes of Microsoft and also that we actually integrate the technology from several leading suppliers, such as Microsoft and Oracle, into our Knowledge Management applications. 1999 has so far been a year of considerable progress for PolyDoc that to-date has not substantially impacted our revenue figures. The benefits of this should have a more substantial impact in the second half of this year with revenue generation being anticipated in most, if not all, of the above mentioned areas. These developments together with the completion of our next round of fund raising will form the foundation from which to move the business forward at an enhanced pace, which in-turn should bring exciting times for both PolyDocs shareholders and staff in the new millennium. Barry Mence or Richard Maddocks (PolyDoc) 0031 20 301 3900 rma@polydoc.com Steve Liebmann (Buchanan Communications) 0171 466 5000 stevel@buchanan.uk.com

Companies

Sopheon (SPE)
UK 100

Latest directors dealings